• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.19% Nasdaq Down 0.10%

    INSYS Therapeutics, Inc. (INSY)

    -NasdaqGM
    17.46 Up 1.09(6.68%) 11:28AM EDT - Nasdaq Real Time Price
    Prev Close:16.37
    Open:17.50
    Bid:17.47 x 200
    Ask:17.53 x 100
    1y Target Est:25.40
    Beta:0.665683
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:17.21 - 18.42
    52wk Range:11.45 - 37.19
    Volume:1,242,422
    Avg Vol (3m):780,298
    Market Cap:1.25B
    P/E (ttm):26.30
    EPS (ttm):0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INSY

    Comparison

    Symbol% ChgMkt Cap
    INSYUp 6.68%1.25B
    ABTUp 0.28%64.72B
    AGNUp 0.13%100.39B

    Key Statistics

    Forward P/E (1 yr):18.62
    P/S (ttm):3.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.40
    Quarterly EPS Est (Sep-16) :0.09
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.46

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the Unit... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback